Choi Eunhee, Duan Cunming, Bai Xiao-Chen
Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.
Nat Rev Mol Cell Biol. 2025 Feb 10. doi: 10.1038/s41580-025-00826-3.
Receptors of insulin and insulin-like growth factors (IGFs) are receptor tyrosine kinases whose signalling controls multiple aspects of animal physiology throughout life. In addition to regulating metabolism and growth, insulin-IGF receptor signalling has recently been linked to a variety of new, cell type-specific functions. In the last century, key questions have focused on how structural differences of insulin and IGFs affect receptor activation, and how insulin-IGF receptor signalling translates into pleiotropic biological functions. Technological advances such as cryo-electron microscopy have provided a detailed understanding of how native and engineered ligands activate insulin-IGF receptors. In this Review, we highlight recent structural and functional insights into the activation of insulin-IGF receptors, and summarize new agonists and antagonists developed for intervening in the activation of insulin-IGF receptor signalling. Furthermore, we discuss recently identified regulatory mechanisms beyond ligand-receptor interactions and functions of insulin-IGF receptor signalling in diseases.
胰岛素和胰岛素样生长因子(IGF)的受体是受体酪氨酸激酶,其信号传导在动物一生中控制着生理的多个方面。除了调节代谢和生长外,胰岛素-IGF受体信号传导最近还与多种新的、细胞类型特异性功能相关联。在上个世纪,关键问题集中在胰岛素和IGF的结构差异如何影响受体激活,以及胰岛素-IGF受体信号传导如何转化为多效性生物学功能。诸如冷冻电子显微镜等技术进步使人们对天然和工程配体如何激活胰岛素-IGF受体有了详细的了解。在本综述中,我们重点介绍了胰岛素-IGF受体激活方面的最新结构和功能见解,并总结了为干预胰岛素-IGF受体信号传导激活而开发的新激动剂和拮抗剂。此外,我们还讨论了最近发现的超越配体-受体相互作用的调节机制以及胰岛素-IGF受体信号传导在疾病中的功能。